Latest Sensorium Therapeutics News & Updates

See the latest news and media coverage for Sensorium. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Sensorium Therapeutics (Sensorium)

Clinical-stage biotech discovering CNS therapies from natural compounds

sensorium.bio
Headquarters
Boston, United States
Founded year
2021
Company type
Private company
Number of employees
25–50
Industry
Pharmaceuticals

Last updated

Latest news about Sensorium Therapeutics (Sensorium)

In short: Sensorium raised $25M in Series A funding, secured FDA IND clearance for SNTX-2643, and appointed Dr. Cole Brown as Chief Medical Officer.

Company announcements

Sensorium

Sensorium receives FDA IND clearance for SNTX-2643

The first-in-class anxiolytic is a precision serotonin modulator, with first-in-human dosing in Q3 2025.

Unlock all announcements with a

Media coverage

KTLA

Sensorium Therapeutics Highlights Promising Data on Lead Assets Targeting Anxiety & Epilepsy at Neuroscience 2024

Preclinical data reveal ongoing progress of lead assets and discovery platform as the company prepares to enter the clinic in early 2025 BOSTON, Oct. 10...

Unlock all articles with a

Never miss news about Sensorium

Track Sensorium and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.